AI assistant
HAEMONETICS CORP — Director's Dealing 2010
Dec 14, 2010
31565_dirs_2010-12-14_ef904b81-6a07-49d0-a1a9-1e2322bb9ef1.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: HAEMONETICS CORP (HAE)
CIK: 0000313143
Period of Report: 2010-12-10
Reporting Person: LINDOP CHRISTOPHER J (CFO & Vice President of)
Non-Derivative Transactions
| Date | Security | Code | Shares | Price | A/D | Holdings After | Ownership |
|---|---|---|---|---|---|---|---|
| 2010-12-10 | Common Stock | M | 8782.0 | $48.09 | Acquired | 19879.0 | Direct |
| 2010-12-10 | Common Stock | S | 8782.0 | $62.7124 | Disposed | 11097.0 | Direct |
| 2010-12-13 | Common Stock | M | 9050.0 | $48.09 | Acquired | 20147.0 | Direct |
| 2010-12-13 | Common Stock | S | 9050.0 | $62.2629 | Disposed | 11097.0 | Direct |
Derivative Transactions
| Date | Security | Exercise Price | Code | Shares | A/D | Expiration | Underlying | Ownership |
|---|---|---|---|---|---|---|---|---|
| 2010-12-10 | Non-Qualified Stock Option (right to buy) | $48.09 | M | 8782.0 | Disposed | 2014-01-25 | Common Stock (8782.0) | Direct |
| 2010-12-13 | Non-Qualified Stock Option (right to buy) | $48.09 | M | 9050.0 | Disposed | 2014-01-25 | Common Stock (9050.0) | Direct |
Holdings (Derivative)
| Security | Exercise Price | Expiration | Underlying | Shares | Ownership |
|---|---|---|---|---|---|
| Non-Qualified Stock Option (right to buy) | $51.07 | 2014-10-24 | Common Stock (21238.0) | 21238.0 | Direct |
| Non-Qualified Stock Option (right to buy) | $52.63 | 2015-10-23 | Common Stock (49020.0) | 49020.0 | Direct |
| Non-Qualified Stock Option (right to buy) | $52.94 | 2016-10-27 | Common Stock (22036.0) | 22036.0 | Direct |
| Non-Qualified Stock Option (right to buy) | $54.55 | 2015-10-22 | Common Stock (21441.0) | 21441.0 | Direct |
| Non-Qualified Stock Option (right to buy) | $54.99 | 2017-10-27 | Common Stock (25095.0) | 25095.0 | Direct |
Footnotes
F1: Total includes Restricted Stock Awards and/or Restricted Stock Units that are subject to restrictions until vesting requirements are met. Grant was made under 2005 Long Term Incentive Compensation Plan.
F2: Grant to reporting person of right to buy shares of common stock exercisable in annual increments of 25 percent beginning on the first anniversary of the date of grant.
F3: Grant to reporting person of right to buy shares of common stock vesting in annual increments over a 5 year period beginning on the first anniversary of the date of grant.